Idexx Laboratories, Inc’s recently made public that its Executive Vice President Hunt Nimrata unloaded Company’s shares for reported $6.63 million on Nov 07 ’25. In the deal valued at $703.34 per share,9,425 shares were sold. As a result of this transaction, Hunt Nimrata now holds 21,149 shares worth roughly $14.17 million.
Then, NIMRATA K HUNT bought 9,425 shares, generating $6,629,060 in total proceeds.
Before that, SZOSTAK M ANNE sold 2,187 shares. Idexx Laboratories, Inc shares valued at $1,415,700 were divested by the Director at a price of $647.33 per share. As a result of the transaction, SZOSTAK M ANNE now holds 262 shares, worth roughly $0.18 million.
Stifel upgraded its Idexx Laboratories, Inc [IDXX] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early October with a ‘”a Neutral”‘ rating. BTIG Research also remained covering IDXX and reiterated its “Buy” recommendation on August 05, 2025. Jefferies started covering the stock on July 01, 2025. It rated IDXX as “a Buy”.
Price Performance Review of IDXX
On Tuesday, Idexx Laboratories, Inc [NASDAQ:IDXX] saw its stock jump 0.18% to $670.21. Over the last five days, the stock has lost -5.93%. Idexx Laboratories, Inc shares have risen nearly 58.20% since the year began. Nevertheless, the stocks have risen 62.11% over the past one year. While a 52-week high of $735.00 was reached on 11/03/25, a 52-week low of $356.14 was recorded on 04/09/25.
Levels Of Support And Resistance For IDXX Stock
The 24-hour chart illustrates a support level at 663.10, which if violated will result in even more drops to 655.98. On the upside, there is a resistance level at 679.48. A further resistance level may holdings at 688.74.
How much short interest is there in Idexx Laboratories, Inc?
A steep rise in short interest was recorded in Idexx Laboratories, Inc stocks on 2025-10-31, dropping by -0.14 million shares to a total of 1.72 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 1.86 million shares. There was a decline of -8.27%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 02, 2024 when Leerink Partners began covering the stock and recommended ‘”an Outperform”‘ rating along with a $500 price target.
